Mountain View-Based Asthmatx Files for $74.75 Million IPO

Mountain View, Calif. -- Asthmatx, a Mountain View-based developer of technology designed to treat asthma, has filed with the Securities and Exchange Commission to raise up to $74.75 million in an initial public offering (IPO). The company, which has applied to list its stock on the Nasdaq under the symbol "AZMA," said that it plans to use $20.0 million of the proceeds for clinical trials and other research and development expenses, and another $20 million for building its commercial infrastructure, incluyding sales and marketing efforts. Asthmatx is developing a technology designed to deliver controlled thermal energy to patients' airways, helping them breathe more easily during asthma attacks.
http://ipoportal.edgar-online.com/ipo/displayFundamentals.asp?cikid=630448&fnid=50854&IPO=1&coname=ASTHMATX+INC
http://www.asthmatx.com/